Aservo EquiHaler 343 microgram
Is the registration number of your country not listed? Then this product falls within the cascade control system.
For the alleviation of clinical symptoms of severe equine asthma.
Aservo EquiHaler 343 microgram
For the alleviation of clinical symptoms of severe equine asthma characterized by coughing, nasal discharge, nasal flaring, increased breathing effort at rest, or abnormal lung sounds.
The newly approved inhaler is designed specifically for use in horses. It includes an ergonomic handle and dosing lever for ease of user handling, and a nostril adaptor that fits gently inside the nostril of the horse, allowing them to easily inhale the medicated mist. The active ingredient in the Aservo® EquiHaler® is the prodrug ciclesonide, which is a corticosteroid that is activated directly in the lung, reducing lower airway inflammation associated with severe equine asthma.
Instructions for use
Day 1 to 5: administer 8 puffs (corresponding to 2.744 μg ciclesonide) twice a day, about 12 hours apart.
Day 6 to 10: administer 12 puffs (corresponding to 4.116 μg ciclesonide) once a day, about 24 hours apart.
